Company Filing History:
Years Active: 2013
Title: Takefumi Hoshikawa: Innovator in Adhesive Skin Patch Technology
Introduction
Takefumi Hoshikawa is a notable inventor based in Higashikagawa, Japan. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of innovative adhesive skin patches. His work focuses on enhancing the therapeutic effects of medications through advanced delivery systems.
Latest Patents
Hoshikawa holds a patent for a water-based adhesive skin patch that contains butenafine hydrochloride. This invention is designed to provide excellent storage stability and effective accumulation of the active ingredient on the skin or nails. The patch is characterized by its formulation, which includes butenafine hydrochloride, glycol salicylate, and propylene glycol in a water-containing gel ointment. The specific mixing ratio of glycol salicylate to propylene glycol ranges from 1:2 to 1:30, ensuring optimal performance.
Career Highlights
Hoshikawa is associated with Teikoku Seiyaku Co., Ltd., a company known for its commitment to pharmaceutical innovation. His work has contributed to advancements in drug delivery systems, particularly in the area of topical treatments. With a focus on improving patient outcomes, Hoshikawa's inventions reflect a deep understanding of both chemistry and medicine.
Collaborations
Hoshikawa has collaborated with notable colleagues such as Takashi Kamakura and Yukiko Inamoto. These partnerships have fostered a creative environment that encourages the development of cutting-edge solutions in the pharmaceutical industry.
Conclusion
Takefumi Hoshikawa's contributions to adhesive skin patch technology exemplify the impact of innovative thinking in medicine. His patent for a butenafine hydrochloride-containing patch showcases his dedication to improving therapeutic efficacy. Through his work, Hoshikawa continues to influence the future of drug delivery systems.